MedPath

Ilaprazole

Generic Name
Ilaprazole
Drug Type
Small Molecule
Chemical Formula
C19H18N4O2S
CAS Number
172152-36-2
Unique Ingredient Identifier
776Q6XX45J

Overview

Ilaprazole has been investigated in Helicobacter Infections.

Indication

用于治疗十二指肠溃疡及反流性食管炎。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR
2024/12/10
NCT06725992
Phase 1
Completed
Il-Yang Pharm. Co., Ltd.
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
2024/02/29
NCT06284876
Phase 3
Recruiting
Il-Yang Pharm. Co., Ltd.
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
2023/05/03
NCT05841394
Phase 3
Completed
Livzon Pharmaceutical Group Inc.
Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T
2022/11/15
NCT05617651
Phase 1
Not yet recruiting
Il-Yang Pharm. Co., Ltd.
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac
2022/09/28
NCT05558150
Phase 1
Completed
Il-Yang Pharm. Co., Ltd.
Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T
2022/08/22
NCT05509543
Phase 1
Completed
Il-Yang Pharm. Co., Ltd.
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
2022/02/14
NCT05237297
Phase 1
Completed
Il-Yang Pharm. Co., Ltd.
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD
2018/02/23
NCT03444883
Phase 3
Completed
Il-Yang Pharm. Co., Ltd.
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
2017/12/05
NCT03362268
Phase 2
Completed
Livzon Pharmaceutical Group Inc.
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
2017/12/05
NCT03362281
Phase 3
Completed
Livzon Pharmaceutical Group Inc.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Ilaprazole Sodium for Injection
丽珠集团丽珠制药厂
国药准字H20170019
化学药品
注射剂
5/16/2022
Ilaprazole Enteric-Coated Tablets
石药集团中诺药业（石家庄）有限公司合并
国药准字H20253336
化学药品
片剂
2/8/2025
Ilaprazole Enteric-Coated Tablets
丽珠集团丽珠制药厂
国药准字H20070256
化学药品
片剂
9/6/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy